Ardelyx, Inc. ARDX

Updated: 16 Jun 2026

NASDAQ | Biotech | Biopharmaceuticals (Kidney & GI diseases)

No signal published yet

We already track Ardelyx and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Ardelyx free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceuticals (Kidney & GI diseases)
We're already tracking Ardelyx, Inc. — here are the latest events we've registered

Recent News

  • On April 30, 2026, Ardelyx reported first-quarter financial results with total product revenue of $93.4 million, reflecting 38% year-over-year growth. The company participated in the Jefferies Global Healthcare Conference on June 3, 2026, and reiterated its full-year revenue guidance for IBSRELA.

What Firelda Watch includes for Ardelyx, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Ardelyx, Inc. will be delivered in the same format.

Want to follow Ardelyx, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Ardelyx free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Ardelyx, Inc. ARDX
Ardelyx — follow and we'll monitor it
Follow Ardelyx free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.